The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Open accessAbstract
BACKGROUND: Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet therapy (combined aspirin, clopidogrel, and dipyridamole) with that of guideline-based antiplatelet therapy. METHODS: We did an international, prospective, randomised, open-label, blinded-endpoint trial in adult participants with ischaemic stroke or transient ischaemic attack (TIA) within 48 h of onset. Participants were assigned in a 1:1 ratio using computer randomisation to receive loading doses and then 30 days of intensive antiplatelet therapy (combined aspirin 75 mg, clopidogrel 75 mg, and dipyridamole 200 mg twice daily) or guideline-based therapy (comprising either clopidogrel alone or combined aspirin and dipyridamole). Randomisation was stratified by country and index event, and minimised with prognostic baseline factors, medication use, time to randomisation, stroke-related factors, and thrombolysis. The ordinal primary outcome was the combined incidence and severity of any recurrent stroke (ischaemic or haemorrhagic; assessed using the modified Rankin Scale) or TIA within 90 days, as assessed by central telephone follow-up with masking to treatment assignment, and analysed by intention to treat. This trial is registered with the ISRCTN registry, number ISRCTN47823388. FINDINGS: 3096 participants (1556 in the intensive antiplatelet therapy group, 1540 in the guideline antiplatelet therapy group) were recruited from 106 hospitals in four countries between April 7, 2009, and March 18, 2016. The trial was stopped early on the recommendation of the data monitoring committee. The incidence and severity of recurrent stroke or TIA did not differ between intensive and guideline therapy (93 [6%] participants vs 105 [7%]; adjusted common odds ratio [cOR] 0·90, 95% CI 0·67-1·20, p=0·47). By contrast, intensive antiplatelet therapy was associated with more, and more severe, bleeding (adjusted cOR 2·54, 95% CI 2·05-3·16, p<0·0001). INTERPRETATION: Among patients with recent cerebral ischaemia, intensive antiplatelet therapy did not reduce the incidence and severity of recurrent stroke or TIA, but did significantly increase the risk of major bleeding. Triple antiplatelet therapy should not be used in routine clinical practice. FUNDING: National Institutes of Health Research Health Technology Assessment Programme, British Heart Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
The SPS3 Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204133 · Cited by 679
Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure
Lees, K. R., Bath, P. M. W., Schellinger, P. D., Kerr, D. M., Fulton, R., Hacke, W., Matchar, D., Sehra, R., & Toni, D. (2012) · Stroke · doi:10.1161/strokeaha.111.641423 · Cited by 242
Self-citationBath, P. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00184.x · Cited by 62
Self-citation
Cited by
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
Johnston, S. C., Easton, J. D., Farrant, M., Barsan, W., Conwit, R. A., Elm, J. J., Kim, A. S., Lindblad, A. S., & Palesch, Y. Y. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800410 · Cited by 1,352
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review
Mendelson, S. J., & Prabhakaran, S. (2021) · JAMA · doi:10.1001/jama.2020.26867 · Cited by 784
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Wang, Y., Meng, X., Wang, A., Xie, X., Pan, Y., Johnston, S. C., Li, H., Bath, P. M., Dong, Q., Xu, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111749 · Cited by 395
Self-citation
Metadata
- Authors
- Bath, P. M., Woodhouse, L. J., Appleton, J. P., Beridze, M., Christensen, H., Dineen, R. A., Duley, L., England, T. J., Flaherty, K., Havard, D., Heptinstall, S., James, M., Krishnan, K., Markus, H. S., Montgomery, A. A., Pocock, S. J., Randall, M., Ranta, A., Robinson, T. G., Scutt, P., Venables, G. S., Sprigg, N., Christensen, L. M., Bentsen, L., Krarup Hansen, C., Thomsen, T. T., Kruuse, C., Jensen, H. H., Hansen, S. S., Petrovic, V, Beridze, N., Kakabadze, N., Kherkheulidze, T., Kakabadze, D., Toidze, I., Lobjanidze, N., Akiashvili, N., Tevdoradze, A., Khizanishvili, N., Tsanava, T., Taylor, R., Iniesta, I., Kok, J., Duignan, J., Funnell, M., Cariga, P., Rodriguez, M., Watson, I. J., Tennant, S., Macleod, M., Furnace, J., Gow, H., Irvine, J., Joyson, A., Nelson, S., Taylor, V, Smith, M., Bellfield, R., Hairsine, B., Davies, R., Dodd, A., Corrigan, J., Doherty, M., Ahmed, A., Denniss, C., Johnson-Holland, S., Kay, K. A., Palau, R. I., Auld, G., Daboo, P., Erande, R., Grimwood, G., Hove, D., Howaniec, L., Redjep, O., Rangasamay, R., Butt, G., Sandler, D., Reddan, J., Stafford, S., McIlmoyle, J., Maguire, S., Murphy, P., Chambers, J., Guthrie, L., Osborn, M., Steele, A., Burn, M., Benford, A., Misra, A., Hilton, D., O'Brien, E., Amis, E., Finlay, S., Mitchell, J., Geraghty, O., Harvey, K., Hazel, B., Mashate, S., Wilding, P., Sajid, M., Ball, M., Gascoyne, R., Sivakumar, R., Wright, A., Chatterjee, K., Booth, S., Eccleson, H., Kelly, C., Leason, S., Perkins, C., Bruce, D., Brown, E., Clayton, S., Garside, M., Rogers, G., Lawrence, E., Mahmood, S., Watchurst, C., Chadha, D., Glover, L., Holford, L., Smith, K., Walstow, D., Williams, R., O'Shea, L., Goodsell, J., Athulathmudali, C., Barbon, E., Namushi, R., Jacob, P., Johnson, L., Morse, D., McGhee, C., Speirs, O., Atkinson, S., Peacocke, A., Langhorne, P., Graham, R., Wright, F., McAlpine, C., Ravindrane, A., Bajoriene, M., Matter, L., Windebank, S., Giallombardo, E., Dellafera, D., Eglinton, C., Wilson, J., Broughton, D., Chapman, K., Dixon, L., Zaidi, M., Ayes, K., Kessell, J., Manawadu, D., Adegbaju, O., Aeron-Thomas, J., Anderson, K., Brigden, A., Cattermole, E., Good, J., Hassan, S., Khoromana, E., Lee-Carbon, L., Marks, K., Mckenzie, E., Sikondari, N., Cooper, M., Whysall, K., Wynter, I., Bamford, J., Hassan, A., Wanklyn, P., Kambafwile, M., Makawa, L., Waugh, D., Veraque, E., Soliman, M., Arif, S., Brown, R., Butler, S., Hewitt, C., Hindle, J., Pusalkar, A., Beadle, H., Chan, K., Siddiqui, M., Dangri, P., Buddha, S., Asokanathan, A., Mistri, A., Eveson, D., Musarrat, K., Manning, L., Anand, S., Christian, P., Khan, S., Patel, C., Sein, M., Banns, J., Gibson, E., Gordon, T., Gruenbeck, Y., Wong, S., Datta, P., Bateman, G., Jackson, L., Needle, A., Duodu, Y., Oliver, R., Padilla-Harris, C., Barber, M., Esson, D., Brodie, F., McInnes, C., Fotherby, K., Butler, D., Morgan, D., Preece, K., Willberry, A., Dent, M., Hammonds, F., Hunt, J., Vernon, C., O'Kane, D., Faola, F., Lai, P., O'Callaghan, J., Smith, C., Price, C., Lakey, R., Riddell, V, Smith, A., Storey, G., Munshi, S., Buck, A., Clarke, J., Gilzeane, N., Godfrey, M., Keshvara, R., Richardson, C., Roffe, J., Ryan, L., Shelton, F., Sunman, W., Tittle, A., Tomlinson, J., Whittamore, K., Wilkes, G., Owusu-Agyei, P., Temple, N., Mangion, D., Hardwick, A., Netherton, K., Nor, A. M., Hyams, B., Norman, S., Persad, N., Ragab, S., Dickson, C., Dube, J., Jinks, E., Knops, K., Wadams, B., Ali, K., Gaylard, J., Spurling, G., Sztriha, L., Ajao, T., Alao, M., Chan, F. K., Webster, P., Howard, P., Dobson, T. J., Hyatt, L., Sims, D., Cunningham, J., Esisi, B., Cassidy, T., Bokhari, M., McClelland, B., Mokoena, B., Gunathilagan, G., Jones, S., Reader, M., Thomas, G., Tilby, S., Findlay, P., Barrett, F., Leslie, F., Ross, S., Shread, I., Okwera, J., Howe, J., Harrington, F., Courtauld, G., Schofield, C., Donnelly, R., Maddula, M., Scott, J., Beavan, J., Muhidden, K., Memon, I., Clarke, M., Hedstrom, A., Mills, L., Hemsley, A., Bowring, A., Boxall, L., Kingwell, H., Keenan, S., Roughan, C., Manoj, A., Cox, P., Fletcher, G., Lopez, P., Emsley, H., Gregary, B., McLoughlin, A., Raj, S., Roffe, C., Abano, N., Barry, A., Butler, A., Carpio, R., Castro, K., Finney, K., Gomm, S., Hiden, J., Grocott, J., Lyjko, S., Maguire, H., Remegoso, A., Sanyal, R., Stevens, S., Natarajan, I., Chembala, J., Muddegowda, G., Warusevitane, A., Blight, A., Balazikova, O., Lawlor, C., Shaw, L., Button, D., Howcroft, D., Lucas, S., Madigan, B., McCann, S., Dixit, A., Barkat, A., Davis, J., Fawcett, M., Finlay, L., Guy, H., Hays, C., Hogg, V, Horsley, E., Hubbuck, C., Pringle, C., Stevenson, C., Storey, K., Thompson, T., Woodward, S., Banerjee, A., Allcock, C., Merotra, S., Douglass, C., Campbell, E., Jarapa, R., Johnes, M., Keaveney, C., Marsden, T., Naing, Z., Perez, J., Shaw, K., Black, T., Anthony, A., Clarke, C., Paterson, J., Deighton, K., Temlett, E., Blank, C., Doyle, C., Duty, S., Gill, K., Harkness, K., Kamara, C., Richards, E., Elfandi, K., Guyler, P., Harman, P., Khuoge, C., Kunhunny, S., Tysoe, S., Moynihan, B., Adedoyin, T., Chopra, N., Dayal, N., Ghatala, R., Jeyaraj, N., Jones, I., Kennedy, F., Kerin, L., Khanom, N., Lewis, S., Maheswaran, S., Montague, L., Niemierko, M., O'Reilly, J., Trippier, S., Watson, F., Wilkinson, P., Young, E., Dizayee, K., Cochrane, H., O'Connell, J., Mokoena, L., Osborne, E., Nair, A., Greig, J., Jenkins, C., Powell, J., Price, F., Chowdhury, M., Brixey, S., Hunt, L., Rands, N., Rose, G., Stoddart, S., Srinivasan, M., Motherwell, N., Shekhar, R., Fuller, T., Lankester, A., Lingwood, P., Rankin, C., Webb, H., Jupp, B., Bell, J., Hann, G., Longland, B., Ovington, C., Bhaskaran, B., Ayres, G., Bailey, C., Bearne, H., Buxton, J., Fitzell, P., Hilaire, C., Kelly, D., Szabo, S., Tomlin, D., Gamble, E., Charles, B., Kumar, R., Fluskey, T., Mellor, Z., Peters, J., Sutton, V, Kenton, A., Martin, I., Nyabadza, S., Ghosh, S., Henry, M., Kumar, B., Bruce, D., Ambulo, C., Crawford, S., Nozedar, T., Platton, M., Cvoro, V, Couser, M., McCormick, K., Wilkinson, D., Javaid, K., Hurdowar, S., Attygalle, T., Sundayi, S., Orugun, O., Crowther, H., Jolly, R., Poultney, U., Azim, A., Krasinska-Chavez, M., White, J., Sengupta, N., Margalef, J., Metiu, M. G., Meenakshisundaram, S., Dealing, S., Hargroves, D., Beranova, E., Cowie, L., Rudenko, H., Thomson, A., Verrion, A., Rashed, K., Board, S., Buckley, C., Hayward, D., Jenkins, K., Keeling, E., Rowland-Axe, R., Vickers, C., Wood, D., Lehman, A., Erande, R., Patel, M., Russell, H., Rehman, H., Forrest, D., & Farren, P.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 391
- Issue
- 10123
- Pages
- 850-859
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2779726076
- Cited by
- 181
- References
- 5
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. https://app.cochat.ai/papers/10.1016/s0140-6736(17)32849-0
- The paper
- Bath, P. M., Woodhouse, L. J., Appleton, J. P., Beridze, M., Christensen, H., Dineen, R. A., Duley, L., England, T. J., Flaherty, K., Havard, D., Heptinstall, S., James, M., Krishnan, K., Markus, H. S., Montgomery, A. A., Pocock, S. J., Randall, M., Ranta, A., Robinson, T. G., . . . Farren, P. (2018). Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. The Lancet. https://doi.org/10.1016/s0140-6736(17)32849-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.